Previous 10 | Next 10 |
Think of the biggest, richest corporations on the planet. They all started out much smaller but grew enormously over time. Investors who spotted their potential early on made fortunes. We asked three Motley Fool contributors to pick monster stocks in the making that just might make inve...
Twist Bioscience (Nasdaq: TWST) and the Australian Research Council (ARC) Centre of Excellence in Synthetic Biology (CoESB) today announced a partnership that will enable CoESB members and partners to order a wide range of Twist products that facilitate research and development. Thi...
Enzolytics ( OTCPK:ENZC ) will work with Abveris, a division of Twist Bioscience ( NASDAQ: TWST ), on the discovery of monoclonal antibodies against several viruses . The initial focus is on antibodies targeting SARS-CoV-2. Terms call for Abveris (also known as...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience will present at the Baird 2022 Global...
Summary Twist Bioscience share price has fallen by 50% since the beginning of 2022. Management thinks DNA data storage could be $2 billion market for the company, aided by early mover advantage and investment in IP. Twist Bioscience recently raised full-year revenue guidance, ...
Gainers: Microvast Holdings ( MVST ) +19% . Hydrofarm Holdings Group ( HYFM ) +7% . Mammoth Energy Services ( TUSK ) +5% . Twist Bioscience ( TWST ) +5% . Certara ( CERT ) +5% . Losers: Bed Bath & Beyond ( BBBY ) ...
Pharmaceutical/biotechnology is the subsector with the highest value and quality scores. Life science tools and healthcare equipment are the most overvalued. Fast facts on IDNA. 10 stocks cheaper than their peers in August. This monthly article series shows a dashboa...
On May 18, I wrote the first of three articles stating that healthcare stocks, and specifically biopharmaceuticals, had likely bottomed. XBI was at 68 and IBB 114. Both XBI and IBB have increased since then. I viewed the valuations a few months ago as being compelling in several insta...
TWST reported its fiscal Q3 results highlighted by strong growth momentum. A new manufacturing facility set to launch in early 2023 is expected to more than double the current capacity. We like TWST as a category leader and see shares rallying higher supported by a positive long-t...
Shares of Twist Bioscience (NASDAQ: TWST) , a biotech company that makes synthetic DNA-based products, including synthetic genes, antibody libraries for drug development and tools for next-generation sample preparation, jumped 25.1% in July, according to according to data from S&a...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...